唾液腺癌的诊断影像学:REFCOR 采用正式共识方法制定的建议
法国罕见头颈肿瘤网络(REFCOR)组建指导组,通过叙述性文献综述和正式共识方法制定唾液腺肿瘤影像学建议。建议:唾液腺肿胀可触及3周时行超声检查;唾液腺肿瘤推荐MRI(含弥散加权和动态对比增强);组织学证实恶性或高度可疑病变时推荐颈部和胸部CT评估肿瘤、淋巴结和转移;FDG-PET目前不推荐用于常规临床实践中的初始诊断、范围评估、治疗反应评价、复发分期或随访。
要点
- 唾液腺肿胀可触及3周时,推荐超声检查确认肿瘤性病变并排除鉴别诊断。
- 唾液腺肿瘤推荐MRI,采用弥散加权和动态对比增强技术。
- 组织学证实恶性或高度可疑病变时,推荐颈部和胸部CT评估肿瘤、淋巴结和转移。
核心结论
- 唾液腺肿瘤的评估以MRI为基础,范围评估以颈部和胸部CT为基础。
研究设计与样本
- REFCOR组建指导组,对Medline发表的文献进行叙述性综述并提出建议,再由评级组按正式共识方法评估对建议的依从性。
诊断标准与关键数值
- 唾液腺肿胀可触及3周时,推荐超声检查确认肿瘤性病变并排除鉴别诊断。
- 唾液腺肿瘤推荐MRI,采用弥散加权和动态对比增强技术。
- 组织学证实恶性或高度可疑病变时,推荐颈部和胸部CT评估肿瘤、淋巴结和转移。
- FDG-PET目前不推荐用于常规临床实践中的初始诊断、范围评估、治疗反应评价、复发分期或随访。
临床应用与阅片要点
- 唾液腺肿胀可触及3周时,超声检查用于确认肿瘤性病变并排除鉴别诊断。
- 唾液腺肿瘤的影像评估以MRI为基础,采用弥散加权和动态对比增强技术。
- 组织学证实恶性或高度可疑病变时,颈部及胸部CT用于评估肿瘤、淋巴结和转移。
- FDG-PET目前不推荐用于常规临床实践中的初始诊断、范围评估、治疗反应评价、复发分期或随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To define the indications for each imaging modality in the screening, characterization, extension and follow-up of salivary gland tumors.
MATERIAL AND METHODS: The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group who drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group, according to the formal consensus method.
RESULTS: If a swelling of a salivary gland is palpable for 3 weeks, an ultrasound scan is recommended to confirm a tumoral lesion and rule out differential diagnoses. For a salivary gland tumor, MRI is recommended with diffusion-weighted and dynamic contrast-enhanced techniques. In the case of histologically proven malignancy or a highly suspicious lesion, a CT scan of the neck and chest is recommended to assess the tumor, lymph nodes and metastases. FDG-PET is not currently recommended in routine clinical practice for initial diagnosis, assessment of extension, evaluation of response to treatment, staging of recurrence, or follow-up of salivary gland tumors.
CONCLUSION: Assessing salivary tumors is based on MRI. Extension assessment is based on neck and chest CT.
引用
- Varoquaux A, Fakhry N, Baujat B, et al. Diagnostic imaging of salivary gland cancers: REFCOR recommendations by the formal consensus method. Eur Ann Otorhinolaryngol Head Neck Dis. 2023. PMID: 38036312. doi:10.1016/j.anorl.2023.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。